UDP-GlcUA triggers PKR kinase activity to promote liquid-liquid phase separation of TOP2A and enhances radioimmunotherapy resistance
Molecular Cell · 2025-11 · 85 (21) · 3913-3929.e9
DOI: 10.1016/j.molcel.2025.10.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2025-11. Verfasst von Hua Yu und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Guangzhou University, Guangzhou, Guangdong 510006, China. Hauptthemen laut MEDLINE: DNA Topoisomerases, Type II, Carcinoma, Hepatocellular, Poly-ADP-Ribose Binding Proteins, Liver Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Liaoning Revitalization Talents Program, National Natural Science Foundation of China, Key Technologies Research and Development Program of Guangzhou Municipality.
Abstract (Originalsprache)
To enhance the effectiveness of irradiation (IR) and optimize PD-1/PD-L1 blockade therapy for hepatocellular carcinoma (HCC), we conducted in vivo CRISPR-Cas9 metabolic sublibrary screening, pinpointing UDP-glucose dehydrogenase (UGDH) as a key target. Post-IR, protein kinase R (PKR) translocates to the nucleus. There, elevated UGDH produces UDP-GlcUA, which binds PKR's dsRNA-binding domain (dsRBD). This binding triggers PKR dimerization, autophosphorylation (T451), and activation. Activated PKR then phosphorylates TOP2A at S1467, inducing its liquid-liquid phase separation (LLPS) and enhancing topoisomerase activity, and finally protects tumor cells from IR-induced DNA damage. Disrupting the UDP-GlcUA/PKR complex reduces TOP2A-S1467 phosphorylation, lowers topoisomerase activity, increases cGAS-STING signaling, and improves anti-PD-L1 immunotherapy efficacy. Clinical HCC sample analysis confirmed the relevance of UDP-GlcUA and the phosphorylation of PKR and TOP2A in response to radiation. Critically, blood UDP-GlcUA may serve as a biomarker for PKR/TOP2A axis activation, guiding patient suitability for anti-PD-L1 immunotherapy after IR and enabling personalized treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Guangzhou University, Guangzhou, Guangdong 510006, China.
- Interdisciplinary Research Center for Biology and Chemistry, Liaoning Normal University, Dalian, Liaoning 116029, China; State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics, Chinese…
- Department of Liver Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
- Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Department of General Surgery, Ruijin-hainan Hospital, Shanghai Jiao Tong University School of Me…
- State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.
- Department of Liver Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China; Department of General Surgery, Hui Ya Hospital of The First Affiliated Hospital, Sun Yat-sen University, Hui…
Förderung
- Liaoning Revitalization Talents Program
- National Natural Science Foundation of China
- Key Technologies Research and Development Program of Guangzhou Municipality
- National Key Research and Development Program of China
- Special Project for Research and Development in Key areas of Guangdong Province
Zitieren
APA
Yu, H., Shi, T., Chu, H., Xu, D., Gong, X., Xiao, L., Liu, Y., Xia, Q., Zhou, Q., Ding, Y., Li, G., & Wang, X. (2025). UDP-GlcUA triggers PKR kinase activity to promote liquid-liquid phase separation of TOP2A and enhances radioimmunotherapy resistance. Molecular Cell, 85(21), 3913-3929.e9. https://doi.org/10.1016/j.molcel.2025.10.011
Vancouver
Yu H, Shi T, Chu H, Xu D, Gong X, Xiao L, et al. UDP-GlcUA triggers PKR kinase activity to promote liquid-liquid phase separation of TOP2A and enhances radioimmunotherapy resistance. Molecular Cell. 2025;85(21):3913-3929.e9. doi:10.1016/j.molcel.2025.10.011
BibTeX
@article{Yu2025,
author = {Yu, Hua and Shi, Tiezhu and Chu, Huiying and Xu, Dongwei and Gong, Xiaoyong and Xiao, Lingyun and Liu, Ye and Xia, Qiang and Zhou, Qi and Ding, Yufeng and Li, Guohui and Wang, Xiongjun},
title = {UDP-GlcUA triggers PKR kinase activity to promote liquid-liquid phase separation of TOP2A and enhances radioimmunotherapy resistance},
journal = {Molecular Cell},
year = {2025},
volume = {85},
number = {21},
pages = {3913--3929.e9},
doi = {10.1016/j.molcel.2025.10.011}
}
EUVIMED